Causes and consequences of the autoimmune lymphoproliferative syndrome

Hematology
V Koneti Rao, Stephen E Straus

Abstract

Autoimmune lymphoproliferative syndrome (ALPS) is the first autoimmune hematological disease whose genetic basis has been defined. It is a disorder of apoptosis in which the inability of lymphocytes to die leads to lymphadenopathy, hypersplenism, and autoimmune cytopenias of childhood onset. More than 200 ALPS patients have been studied over the last 15 years and followed by our colleagues and ourselves at the Clinical Center of the National Institutes of Health. Based upon this experience we have determined that patients with germline mutations of the intracellular domain of Fas protein, the most frequent single genetic cause of ALPS, have a significantly increased risk of developing Hodgkin and non-Hodgkin lymphoma (NHL), underscoring the critical role played by cell surface receptor-mediated apoptosis in eliminating redundant proliferating lymphocytes with autoreactive and oncogenic potential. The major determinants of morbidity and mortality in ALPS are the severity of the autoimmune disease, hypersplenism, asplenia-related sepsis, and the risk of lymphoma, which in itself requires long-term surveillance. Though most episodes of cytopenias respond to courses of conventional immunomodulatory agents, some ALPS patients, espec...Continue Reading

References

Aug 1, 1992·The Journal of Clinical Investigation·M C SnellerW Strober
Jan 1, 1991·Annual Review of Immunology·P L Cohen, R A Eisenberg
Jun 1, 1967·The Journal of Pediatrics·V C Canale, C H Smith
Feb 1, 1997·Seminars in Immunology·M J Lenardo
Aug 1, 1997·European Journal of Immunology·M BenkerrouA Fischer
Aug 29, 1998·Bone Marrow Transplantation·B J SleightC L Sidman
Nov 12, 1998·The American Journal of Pathology·M S LimE S Jaffe
Mar 26, 1999·American Journal of Human Genetics·C E JacksonJ M Puck
Apr 3, 1999·Annals of Internal Medicine·S E StrausW Strober
Dec 11, 1999·Current Opinion in Pediatrics·C E Jackson, J M Puck
Feb 26, 2000·British Journal of Haematology·B Bader-MeunierG Tchernia
Jun 22, 2000·American Journal of Hematology·B S FangM E Rick
Sep 23, 2000·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·M MüschenM W Beckmann
Feb 13, 2001·Transfusion·D F StroncekS E Straus
May 9, 2001·Leukemia & Lymphoma·J Van Der Werff Ten BoschK Thielemans
May 16, 2002·Blood·Min Sun ShinSug Hyung Lee
Aug 30, 2002·British Journal of Haematology·Bridget T HeelanA David B Webster
Mar 26, 2003·Seminars in Cancer Biology·Klaus Michael DebatinSimone Fulda
Mar 26, 2003·Cell Death and Differentiation·F Rieux-LaucatA Fischer
Jun 24, 2003·Current Opinion in Rheumatology·Michael C SnellerStephen E Straus
Sep 9, 2004·British Journal of Haematology·Catherine BurtonDavid Linch
Oct 2, 2004·The New England Journal of Medicine·Jennifer M Puck, Stephen E Straus
Oct 2, 2004·The New England Journal of Medicine·Eliska HolzelovaFrédéric Rieux-Laucat
Jun 3, 2005·Nature·John D Rioux, Abul K Abbas
Jun 9, 2005·Blood·Douglas B Cines, James B Bussel

❮ Previous
Next ❯

Citations

Jan 15, 2008·Journal of Clinical Immunology·João Bosco Oliveira, Sudhir Gupta
Jul 18, 2009·International Journal of Hematology·Zorica D JuranićIvana Minić
May 17, 2007·Acta Haematologica·Osnat Bairey, Ofer Shpilberg
Feb 6, 2010·Journal of Translational Medicine·Robert B NussenblattAlan N Schechter
Mar 15, 2011·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·C JarrasséD Plantaz
Apr 18, 2009·Leukemia & Lymphoma·Damali N MartinOla Landgren
Feb 11, 2015·Clinical Reviews in Allergy & Immunology·Pu LiFei Li
Sep 24, 2013·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·C Garrido Colino
Mar 30, 2013·Seminars in Diagnostic Pathology·Amy Chadburn
Feb 23, 2010·Autoimmunity Reviews·Joseph C Turbyville, V Koneti Rao
Feb 2, 2010·Hematology/oncology Clinics of North America·Victor Blanchette, Paula Bolton-Maggs
Nov 26, 2009·Hematology/oncology Clinics of North America·Carolyn M Bennett, Michael Tarantino
Mar 21, 2007·American Journal of Clinical Pathology·Roger A WarnkeEric D Hsi
Apr 22, 2008·Immunology and Allergy Clinics of North America·Helen C Su, Michael J Lenardo
Apr 3, 2008·Pediatric Clinics of North America·Victor Blanchette, Paula Bolton-Maggs
Oct 11, 2014·The Journal of Obstetrics and Gynaecology Research·Simona PattiRoberto Brunelli
Oct 23, 2012·Journal of Autoimmunity·Owen NgalamikaQianjin Lu
Sep 3, 2011·Blood·V Koneti Rao, João Bosco Oliveira
Aug 6, 2016·Journal of Clinical Immunology·Hikmet G TanyildizNurdan Tacyildiz
Dec 23, 2009·Pediatrics·Nora Naumann-BartschWolfgang Holter

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.